Search
Search Results
-
Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fraction
ObjectiveMagnetic resonance spectroscopy (MRS) provides a powerful method of measuring fat fraction. However, previous studies have shown that MRS...
-
MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma
ObjectivesImage-based detection of intralesional fat in focal liver lesions has been established in diagnostic guidelines as a feature indicative of...
-
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study
BackgroundSeveral preliminary reports have suggested the utility of ultrasound attenuation coefficient measurements based on B-mode ultrasound, such...
-
Assessing breast density using the chemical-shift encoding-based proton density fat fraction in 3-T MRI
ObjectivesThere is a clinical need for a non-ionizing, quantitative assessment of breast density, as one of the strongest independent risk factors...
-
Longitudinal MR-based proton-density fat fraction (PDFF) and T2* for the assessment of associations between bone marrow changes and myelotoxic chemotherapy
ObjectivesMR imaging-based proton density fat fraction (PDFF) and T2* imaging has shown to be useful for the evaluation of degenerative changes in...
-
Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software
ObjectiveTo validate the proton density fat fraction (PDFF) obtained by the MRQuantif software from 2D chemical shift encoded MR (CSE–MR) data in...
-
Assessment of hepatic fat content and prediction of myocardial fibrosis in athletes by using proton density fat fraction sequence
PurposeTo explore the characteristics of the hepatic fat content in athletes, and predict late gadolinium enhancement (LGE) based on magnetic...
-
Influence of Gd-EOB-DTPA on proton-density fat fraction in the liver using chemical shift-encoded magnetic resonance imaging at 3-T
Non-alcoholic fatty liver disease (NAFLD) and its advanced stage, non-alcoholic steatohepatitis (NASH), have become increasingly prevalent owing to...
-
The effect of hepatic steatosis on liver volume determined by proton density fat fraction and deep learning–measured liver volume
ObjectivesWe aimed to evaluate the effect of hepatic steatosis (HS) on liver volume and to develop a formula to estimate lean liver volume correcting...
-
Quantitative ultrasound fatty liver evaluation in a pediatric population: comparison with magnetic resonance imaging of liver proton density fat fraction
BackgroundBiopsy remains the gold standard for the diagnosis of hepatic steatosis, the leading cause of pediatric chronic liver disease; however, its...
-
Influence of Gadoxetate disodium to the hepatic proton density fat fraction quantified with the Dixon sequences in a rabbit model
ObjectiveTo study the impact of Gx on quantification of hepatic fat contents under metabolic dysfunction-associated steatotic liver disease (MASLD)...
-
MRI-derived proton density fat fraction
Reflecting the growing interest in early diagnosis of nonalcoholic fatty liver disease in recent years, the development of noninvasive and reliable...
-
Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction
PurposeInternational expert panels proposed new nomenclatures, metabolic dysfunction-associated fatty liver disease (MAFLD) in 2020 and metabolic...
-
Linearity and bias of proton density fat fraction across the full dynamic range of 0–100%: a multiplatform, multivendor phantom study using 1.5T and 3T MRI at two sites
ObjectivePerformance assessments of quantitative determinations of proton density fat fraction (PDFF) have largely focused on the range between 0 and...
-
Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma
BackgroundMagnetic resonance (MR) elastography and proton density fat fraction (PDFF) are emerging techniques for non-invasive assessment of liver...
-
Adding liver R2* quantification to proton density fat fraction MRI of vertebral bone marrow improves the prediction of osteoporosis
ObjectivesTo assess the predictive value of the combination of bone marrow (BM) proton density fat fraction (PDFF) and liver R2* for osteopenia and...
-
Clinical significance of hepatic fat loss in chronic liver disease: a study using MRI proton density fat fractionation
Background/AimsThe liver plays a central role in the fatty acid metabolism. Therefore, cirrhosis is prone to energy malnutrition and is associated...
-
Quantitative MR evaluation of the infrapatellar fat pad for knee osteoarthritis: using proton density fat fraction and T2* relaxation based on DIXON
ObjectivesTo investigate the efficacy of fat fraction (FF) and T2* relaxation based on DIXON in the assessment of infrapatellar fat pad (IFP) for...
-
Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content
PurposeTo compare ultrasound (US) and US-derived fat fraction (UDFF) with magnetic resonance proton density fat fraction (MRI-PDFF) for the detection...
-
Intra-examination agreement between multi-echo gradient echo and confounder-corrected chemical shift-encoded MR sequences for R2* estimation as a biomarker of liver iron content in patients with a wide range of T2*/R2* and proton density fat fraction values
PurposeTo investigate the intra-examination agreement between multi-echo gradient echo (MEGE) and confounder-corrected chemical shift-encoded (CSE)...
